Summary & Overview
CPT 81376: HLA Class II Typing, Low/Intermediate-Resolution Technical
CPT code 81376 covers the technical laboratory component for low- or intermediate-resolution molecular assessment of human leukocyte antigen (HLA) genes at one Class II locus. This code is used for laboratory processing and analysis when HLA Class II typing is required for transplant compatibility, immunogenetics evaluations, or other clinical indications where class II allele group identification is sufficient.
Nationally, HLA testing supports transplant matching, donor selection, and certain disease risk assessments, making accurate coding and reimbursement important for labs and providers. Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. When present in a claim, CPT code 81376 identifies the technical component of molecular HLA Class II testing performed at clinical or hospital laboratories.
Readers will find benchmarks and context on service utilization and coding practice, relevant clinical context about HLA Class II testing, and notes on payer coverage patterns and policy considerations where available. Data not available in the input will be identified as such.
Billing Code Overview
CPT code 81376 describes a technical laboratory test that performs low- or intermediate-resolution molecular assessment of human leukocyte antigen (HLA) genes for a single Class II locus. The service involves laboratory processing and analysis using molecular techniques to determine HLA Class II typing at a resolution level used for clinical matching and immune compatibility assessment.
Service Type: Laboratory — Molecular HLA Class II typing (technical component)
Typical Site of Service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A 32-year-old patient evaluated for kidney transplantation is referred for HLA typing to assess donor-recipient compatibility. The ordering clinician is a transplant nephrologist who requests low- or intermediate-resolution molecular testing of a single Class II HLA locus (for example HLA-DR or HLA-DQ) to inform panel reactive antibody interpretation and organ allocation. A phlebotomy nurse collects a peripheral blood sample and sends it with the requisition to the molecular diagnostics laboratory. The laboratory technologist performs nucleic acid extraction and runs the appropriate molecular assay for 81376 (low/intermediate resolution assessment of one Class II locus). Results are reviewed and finalized by a qualified laboratory director, and the report is returned to the transplant team. Typical sites of service include an independent clinical molecular laboratory, hospital-based clinical laboratory, or an academic medical center molecular diagnostics lab. The service is technical in nature and is billed for the laboratory test component of HLA Class II typing using molecular techniques.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When reporting the physician/clinical interpretation and report separate from the laboratory technical component (rare for purely technical lab codes). |